Amelioration of Liver Injury by Continuously Targeted Intervention against TNFRp55 in Rats with Acute-on-Chronic Liver Failure

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Xu, Yumin ^a   Wang, Hui ^a   Bao, Shishan ^b   Tabassam, Fazal ^c   Cai, Wei ^a   Xiang, Xiaogang ^a   Zhao, Gangde ^a   Wu, Haiqing ^a   Gao, Ting ^a   Li, Hai ^a   Xie, Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLINE; GALACTOSAMINE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 22; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P55; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR IMMUNOGLOBULIN G FC; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE ON CHRONIC LIVER FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER FIBROSIS; MORTALITY; NONHUMAN; RAT; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; GALACTOSAMINE; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE; LIVER FAILURE, ACUTE; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT FUSION PROTEINS; SERUM ALBUMIN; TUMOR NECROSIS FACTOR DECOY RECEPTORS;

EID: 84880501099     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068757     Document Type: Article

References (24)

1. Liu Q, (2009) Role of cytokines in the pathophysiology of acute-on-chronic liver failure. Blood Purif 28: 331-341.
2. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, et al. (2009) Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 3: 269-282.
3. An F, Gong B, Wang H, Yu D, Zhao G, et al. (2012) miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis 17: 702-716.
4. Hatano E, (2007) Tumor necrosis factor signaling in hepatocyte apoptosis. J Gastroenterol Hepatol 22Suppl 1: S43-44.
5. Leist M, Gantner F, Jilg S, Wendel A, (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154: 1307-1316.
6. Gao T, Xu Y, Gong Y, Wang H, Xie Q, et al. (2012) Continuously blocking tumor necrosis factor-alfha signal transduction prevent acute or acute-on-chronic liver failure mice from death effectively. J Hepatol 56: S101.
7. Zhan J, Chen Y, Yuan HY, Li H, Lu H, (2012) Fusion of HSA influences TNF-alpha neutralizing activity of shTNFRs. Biotechnol Lett 34: 417-423.
8. Deng C, Liu J, Wang G, Ma L, Xie C, et al. (2012) A novel small molecule, (E)-5-(2,4-di-tert-butyl-6-((2,4-dioxothiazolidin-5-ylidene)methyl)phenyl)-5′-met hyl-7,7′-dimethoxy-4,4′-bibenzo[d][1,3]dioxole-5,5′-dicarboxylate (7k), alleviates the development of D-galactosamine/lipopolysaccharide-induced acute liver failure by inhibiting macrophage infiltration and regulating cytokine expression. J Pharmacol Exp Ther 341: 146-155.
9. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, et al. (2010) Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52: 1291-1300.
10. Streetz K, Leifeld L, Grundmann D, Ramakers J, Eckert K, et al. (2000) Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119: 446-460.
11. Yang L, Zhang Y, Wang L, Fan F, Zhu L, et al. (2010) Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J Hepatol 53: 339-347.
12. Xiang X, Gui H, King NJ, Cole L, Wang H, et al. (2012) IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunol Cell Biol 90: 611-619.
13. Aggarwal S, Xie MH, Maruoka M, Foster J, Gurney AL, (2001) Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res 21: 1047-1053.
14. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
15. Porter AG, Janicke RU, (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104.
16. Patel S, Chung SH, White G, Bao S, Celermajer DS, (2010) The "atheroprotective" mediators apolipoprotein A-I and Foxp3 are over-abundant in unstable carotid plaques. Int J Cardiol 145: 183-187.
17. Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, et al. (1997) A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 94: 690-694.
18. Ni HM, Chen X, Ding WX, Schuchmann M, Yin XM, (2008) Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. Am J Pathol 173: 962-972.
19. Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, et al. (2009) The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol 51: 475-482.
20. Park JS, Yoon U, Kwak KC, Seo SW, Kim SI, et al. (2011) The relationships between extent and microstructural properties of the midsagittal corpus callosum in human brain. Neuroimage 56: 174-184.
21. Xing WW, Zou MJ, Liu S, Xu T, Gao J, et al. (2011) Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice. Cytokine 56: 174-179.
22. James LP, Mayeux PR, Hinson JA, (2003) Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 31: 1499-1506.
23. Fujii T, Fuchs BC, Yamada S, Lauwers GY, Kulu Y, et al. (2010) Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor. BMC Gastroenterol 10: 79.
24. Salama SM, Abdulla MA, AlRashdi AS, Ismail S, Alkiyumi SS, et al. (2013) Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats. BMC Complement Altern Med 13: 56.